Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Connecticut Children's Medical Center, Hartford, Connecticut, United States
Contact: Study coordinator (Dena Hopkins, MPH) · DHopkins01@connecticutchildrens.org · 1-(860)-545-8125
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Contact: Study coordinator (Ramona Bezold, BSN) · Ramona.Bezold@cchmc.org · 1-(513)-636-1412
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Jennifer Dotson, MD) · Jennifer.Dotson@nationwidechildrens.org
Contact: Principal Investigator (Jennifer Dotson, MD)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Subcutaneous Infliximab After A Previous Intravenous Dose Optimization

Inflammatory Bowel Diseases · Crohn Disease · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE4

Ghent, Belgium · Ostend, Belgium

Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease

IBD · Crohn Disease · Ulcerative Colitis (UC)

Abroad (travel likely)RecruitingPHASE2

Paris, France

Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease

Ulcerative Colitis (UC) · Crohn Disease (CD)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Groningen, Netherlands

Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context

Crohn Disease (CD) · Ulcerative Colitis (UC)

Abroad (travel likely)Recruiting

Bonheiden, Belgium